A biomimetic nanodrug for enhanced chemotherapy of pancreatic tumors

Pancreatic ductal adenocarcinoma (PDAC) remains to be one of the highest malignant tumors due to its poor chemotherapeutic efficacy and multidrug resistance. A major reason for the failure in chemotherapy is poor drug accumulation into PDAC tumor tissues due to the overexpressed extracellular matrix (ECM) stroma, which forms a major obstacle limiting the deep tissue penetration of chemotherapeutics. Herein, we report a tumor micro -environment (TME)-responsive nanodrug, based on PDAC cell membrane-coated gold nanocages (AuNCs), to co -deliver the chemotherapeutics (GEM) and nitrogen oxide (NO) donor (L-Arg) to enhance drug accumulation and reduce chemoresistance. The high glutathione (GSH) level can trigger the cleavage of the disulfide bond on nanodrug to release GEM. Moreover, the elevated ROS level could activate L-Arg to generate NO, which syn-ergistically facilitate GEM to penetrate into deep tissues by means of vasodilation and normalization of blood vessels in the PDAC tumor tissue. In addition, AuNCs not only serve as a photothermal agent for chemotherapy, but also generate photoacoustic signals to monitor drug accumulation and distribution. As expected, the strategy demonstrates to be remarkable in treating different xenograft mice models, especially in orthotopic and patient -derived xenograft (PDX) models. The current study defines a useful therapeutic tool for treating PDAC tumors.

Automated summary

This study presents a tumor microenvironment (TME)-responsive nanodrug, based on pancreatic ductal adenocarcinoma (PDAC) cell membrane-coated gold nanocages (AuNCs), for co-delivery of chemotherapeutics (GEM) and nitrogen oxide (NO) donor (L-Arg) to enhance drug accumulation and reduce multidrug resistance.